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Activation-induced cytidine deaminase (AID) is an APO BEC- 
related enzyme that is essential in the affinity maturation of Ig 
heavy (IgH) and light (Ig-κ or Ig-λ, together referred to as IgL) 
chains during B cell differentiation (for review see Hwang et 
al. [2015]). Encounter between a mature B cell, its cognate 
antigen, and an antigen-specific T cell results in B cell activa-
tion and the expression of the transcriptional repressor BCL6 
that is essential for the formation and maintenance of germi-
nal centers (GCs) in secondary lymphoid tissue. BCL6-ex-
pressing B cells enter or initiate GCs and express high levels 
of AID that introduce somatic hypermutation (SHM) in the 
variable region of IgH and IgL through deamination of cy-
tosine residues, which can be repaired by error-prone repair 
mechanisms to generate point mutants, some of which in-
crease the affinity of membrane Igs for their cognate antigen. 
This is responsible for the process of affinity maturation. In 
addition, AID can cause DNA double-strand breaks that lead 
to Ig class switch recombination and the generation of B cells 
expressing IgG, IgA, or IgE (Hwang et al., 2015).
In addition to SHM and class switch recombination, 
AID is known to cause off-target lesions at non-Ig loci across 
the genome that can result in mutations and translocations 
in the development of cancer (for review see Robbiani and 
Nussenzweig [2013]). Many human B cell lymphomas are 
GC derived and express AID outside of the GC environment; 
these include Burkitt lymphoma (BL). BL are defined by char-
acteristic chromosome translocation between the oncogene 
c-MYC and IgH or IgL, resulting in constitutive activation of 
c-MYC, but additional mutations of tumor suppressors, e.g., 
TP53, CDKN2A, or BCL2L11 (BIM), are required for lym-
phomagenesis (for review see Schmitz et al. [2014]). The en-
demic form of BL (eBL) is etiologically associated with EBV 
and malaria (Plasmodium falciparum) infection (for review 
see Thorley-Lawson and Allday [2008]). Recently, it has been 
shown that P. falciparum can induce AID in human tonsillar 
B cells and that chronic malaria infection is associated with 
an increased GC transition of B cells (Torgbor et al., 2014). 
Furthermore, it was also shown that chronic malaria infection 
creates a GC environment favorable for the development of 
AID-dependent mature B cell lymphoma in a mouse model 
of Plasmodium chabaudi infection (Robbiani et al., 2015). 
However, until now, EBV was not regarded as actively driving 
eBL lymphomagenesis, but rather compensating for c-MYC–
induced proliferative stress by repressing tumor suppressors 
and apoptosis-related factors, e.g., CDKN2A and BCL2L11 
(for review see Allday [2009] and Rowe et al. [2009]).
EBV is a human gamma-herpesvirus first discovered in 
eBL biopsies but also associated with other B cell lymphoma, 
e.g., Hodgkin lymphoma and immunoblastic lymphoma in 
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the immunosuppressed (for review see Young and Rickin-
son [2004]). However, most EBV infections occur early in 
life and have resulted in >90% of the global adult human 
population being asymptomatically and persistently infected. 
Infection of resting B cells with EBV results in activation and 
transformation into proliferating B blasts induced by the ex-
pression of EBV latency–associated genes producing six EBV 
nuclear antigens (EBNA1, 2, 3A, 3B, and 3C and leader pro-
tein), three latent membrane proteins (LMP1, 2A, and 2B), 
two small noncoding RNAs (EBER1 and 2), and microRNA 
transcripts from the BamHI A region (BARTs; Young and 
Rickinson, 2004; Skalsky and Cullen, 2015). The proliferat-
ing, infected B blasts, carrying extrachromosomal EBV ep-
isomes, then transit through a GC, and this is accompanied by 
gradual shutdown of viral gene expression and B cell differ-
entiation, resulting in long-term persistence in the memory 
B cell population (for review see Thorley-Lawson [2015]). In 
vitro, infection of primary resting B cells with EBV creates 
continuously proliferating lymphoblastoid cell lines (LCLs) 
that again carry viral episomes constitutively expressing all of 
the latency-associated EBV genes.
In addition to the antiapoptotic role of EBV in B cell 
lymphomagenesis, various studies suggested that EBV infec-
tion could induce expression of AID (He et al., 2003; To-
bollik et al., 2006; Epeldegui et al., 2007; Gil et al., 2007; 
Heath et al., 2012). However, none of these studies addressed 
the mechanism, definitively identified the EBV gene product 
responsible for the up-regulation, or ruled out preferential 
outgrowth of infected B cells with a preexisting high level of 
AID expression. Microarray analysis identified EBNA3C as a 
potentially important factor in the induction of AID (Skalska 
et al., 2013). EBNA3C is one of the viral oncoproteins that 
are essential for the in vitro transformation of B cells into 
LCLs and primarily acts as a transcriptional regulator of host 
gene expression (for review see Allday et al. [2015]). Here, we 
provide definitive evidence that EBNA3C is essential for the 
specific induction of AID in EBV-infected B cells and might 
therefore play a more active role in B cell lymphomagenesis 
than previously assumed.
RES ULTS AND DIS CUS SION
EBNA3C is necessary for the induction of AID  
after infection of primary resting B cells with EBV
We interrogated a sense target microarray (Exon 1.0 ST; 
Affymetrix) with cDNA from EBNA3C-conditional LCLs 
(3CHT) and identified EBNA3C as a potential viral factor 
necessary for the induction of AID because AIC DA was the 
gene most highly up-regulated by EBNA3C (Skalska et al., 
2013). To establish that AID is actually regulated by EBNA3C 
during viral infection, primary CD19+ B cells were infected 
with previously constructed and characterized EBNA3C 
KO and revertant (Rev) EBV recombinants (Anderton et al., 
2008). Infection with EBNA3C Rev virus resulted in a grad-
ual induction of AID mRNA to high levels (>20-fold above 
resting B cells) over a period of ∼30 d (Fig. 1). However, this 
induction of AID was not observed after infection with EB-
NA3C KO virus; here, AID mRNA levels remained similar 
to those seen in the uninfected primary B cells. This identi-
fied EBNA3C as an essential factor for the induction of AID 
and also ruled out the possibility that EBV infection led to 
the preferential outgrowth of B cells with a preexisting high 
level of AID expression. Moreover, consistent with previous 
studies (Gil et al., 2007; Heath et al., 2012), BCL6 was well 
repressed by EBV, and this was independent of the presence 
or absence of functional EBNA3C over the same period (Fig. 
S1 A). This suggests that EBV transformation does not mimic 
the establishment of GC-like cells in other critical respects.
Regulation of AID can be recapitulated  
in EBNA3C-conditional LCLs
Having established that EBNA3C is essential for the induc-
tion of AID after primary infection, we wanted to deter-
mine whether this was recapitulated in the 3CHT LCLs 
that carry EBV recombinants with conditional EBNA3C. 
In these cell lines, EBNA3C activity is conditional on the 
presence of 4-hydroxytamoxifen (HT), but proliferation of 
the cells does not decrease in its absence because of the ho-
mozygous deletion of p16INK4A, a primary target of EBNA3C 
(Skalska et al., 2013). An LCL could therefore be established 
in the absence of functional EBNA3C or high levels of 
AID (3CHT A13). Activation of EBNA3C by the addition 
of HT to these cells (+HT) resulted in an increase of AID 
Figure 1. EBNA3C induces AID expression after infection of primary 
B cells with EBV and in EBNA3C-conditional LCLs. Primary B cells 
infected with EBNA3C KO (3CKO) or revertant (3CRev) recombinant EBV 
were cultured over a period of 30 d. EBNA3C-conditional LCLs (3CHT) were 
cultured over a period of 30 d in the absence (−HT) or presence (+HT) of HT. 
AID mRNA expression was normalized to GAP DH or GNB2L1 and is shown 
relative to uninfected primary B cells or 3CHT cells on day 0. Results show 
the mean ± SD of three biological replicates. B cells from different donors 
were used for the infections. Please note that the day 30 time point of 
3CKO-infected primary B cells shows the mean of two replicates.
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mRNA expression very similar in magnitude and timing to 
that seen after infection of primary B cells with EBNA3C 
Rev virus (Fig. 1). No increase in AID levels was observed 
when EBNA3C remained inactive (−HT), which displayed 
AID levels comparable with resting B cells or primary B cells 
infected with EBNA3C KO virus.
Fig.  2 (A and B) shows a representative 3CHT time 
course over a 60-d period. Maximal AID mRNA (Fig. 2 A) 
and protein (Fig. 2 B) expression levels were detected 30 d 
after activation of EBNA3C, which was fully reversible by 
inactivation of EBNA3C after withdrawal of HT. In the ab-
sence of functional EBNA3C, 3CHT cells expressed AID at 
levels similar to uninfected primary B cells, and when EB-
NA3C was switched on, AID levels were comparable with 
those in various BL cell lines and various LCLs independently 
established with B95.8 EBV (Figs. 2, C and D). Some LCLs 
expressed remarkably large amounts of AID mRNA and pro-
tein, and it is perhaps worth noting that GM12878, which was 
used as the tier 1 LCL in the Encyclopedia of DNA Elements 
(ENC ODE), is one of them.
EBNA3C targets highly conserved regulatory elements  
to induce epigenetic changes for AID expression
Next, to determine whether induction of AID is a direct or 
indirect effect of EBNA3C expression, we analyzed chro-
matin immunoprecipitation (ChIP) coupled to sequenc-
ing (ChIP-Seq) performed on tandem-affinity purification 
(TAP)–tagged EBNA3C-expressing LCLs (unpublished 
data). This revealed EBNA3C occupancy at most (4/5) of 
the previously identified and highly conserved regulatory 
regions of the AIC DA gene (Fig.  3 A). Region I contains 
the AIC DA promoter, region II is located within the first 
intron, and region IV is located ∼17 kb upstream of the tran-
scriptional start site (Zan and Casali, 2013). In addition, two 
more recently identified regions, V and VI, are situated ∼32 and 
∼36 kb upstream of the transcriptional start site, respectively 
(Kieffer-Kwon et al., 2013). Most of these regions were initially 
identified in mouse B cells, but they are highly conserved in 
human B cells, and the whole locus has been called the AID/
AIC DA superenhancer (Fig. 3 A; Qian et al., 2014). Different 
levels of EBNA3C occupancy were observed at these regula-
tory elements in the following order of magnitude: VI > IV > 
II > V, which was confirmed by ChIP-qPCR (Fig. S2).
Therefore, it seemed that the induction of AID was 
a direct effect of EBNA3C binding to regulatory regions 
at the AIC DA locus, which raised the question of how 
EBNA3C induced AID expression. EBNA3C is primar-
ily known as a transcriptional coregulator, but it has been 
studied most frequently in gene repression (Allday et al., 
2015). ChIP samples harvested during the 3CHT time 
course from cells expressing functional or nonfunctional 
EBNA3C were therefore analyzed for changes in activa-
Figure 2. Induction of AID mRNA and protein in EBNA3C-conditional LCLs and comparison across various cell lines. (A) Time course using EB-
NA3C-conditional LCL 3CHT A13. Cells were grown over a period of 60 d in the absence of HT (−HT), in the presence of HT (+HT), or with HT removed after 
30 d +HT (washed). Gene expression for AID was normalized to GAP DH and is shown relative to −HT on day 0. (B) Western blot showing AID and γ-tubulin 
protein expression in selected samples (numbers indicate time point) of the 3CHT A13 time course shown in A. (C) AID mRNA expression in 3CHT LCLs, three 
in-house B95.8 EBV–transformed LCLs (1, 2, and 3), LCL GM12878, Ramos (EBV-negative BL), EBV-positive BL (latency I Akata [not expressing EBNA3C], EBV 
W-promoter [Wp]–restricted Oku [expressing EBNA3C], and latency III Namalwa [expressing EBNA3C]), BJAB (EBV-negative B cell lymphoma), and K562 
(EBV-negative erythromyeloblastoid leukemia) were normalized to GAP DH and are shown relative to primary B cells. Results show the mean ± SD of three 
technical replicates. (D) AID and γ-tubulin protein expression in samples shown in C. A and B show representative results of three biological replicates, and 
C and D show representative results of at least two biological replicates.
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Figure 3. EBNA3C specifically targets regulatory elements and epigenetically controls AID expression. (A) University of California, Santa Cruz 
(UCSC) genome browser overview of AID genomic locus (AIC DA) showing model-based analysis of ChIP-Seq (MACS) peaks for EBNA3C-TAP, mouse se-
quence alignment, and primer locations for ChIP-qPCR. Anti-Flag ChIP-Seq signals from EBNA3C-TAP–tagged and untagged wild-type LCLs were displayed 
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tion-associated histone marks H3K4me3, H3K9ac, and 
H3K27ac. There was an increase of H3K4me3 at regions I 
and II only when EBNA3C was functional (Fig. 3 B). Fur-
thermore, there was an increase of H3K9ac and H3K27ac 
at these two sites and also on region V, again only when 
EBNA3C was functional (Figs. 3, C and D). One of the few 
transcriptional coactivators with which EBNA3C has been 
reported to physically interact is the histone acetyltransfer-
ase p300 (Subramanian et al., 2002). ChIP for p300 showed 
that there was a transient recruitment of p300 mainly to 
regions IV and VI, again only when EBNA3C was func-
tional (Fig. 3 E). The timing of the recruitment is consis-
tent with the increase in histone acetylation at regions I, II, 
and V; however, we were surprised because histone acetyl-
ation levels did not increase at regions IV and VI, the two 
sites where most p300 could be detected, but at sites up to 
20 kb away from them. Consistent with this, it has been 
shown that in activated mouse B cells, regions IV, V, and VI 
form long-range interactions with regions I and II when 
AID is expressed (Kieffer-Kwon et al., 2013). This can also 
be seen in Hi-C data from GM12878 cells that express 
EBNA3C and relatively high levels of AID (Fig. 2 and Fig. 
S3; Rao et al., 2014). It is therefore likely that p300 binds 
at regions IV and VI but catalyzes the histone acetylation at 
regions I, II, and V. EBNA3C cannot bind directly to DNA, 
but recombination binding protein J (RBPJ; also known 
as CBF1/CSL), the Notch pathway–associated transcrip-
tion factor, is a well characterized DNA-binding protein 
with which EBNA3C interacts (Allday et al., 2015), so 
ChIP for RBPJ was performed (Fig.  3  F). This revealed 
that RBPJ occupancy transiently increased at all regions 
where active EBNA3C was found, and the levels of re-
cruited RBPJ correlated well with the levels of EBNA3C 
detected by ChIP-Seq (region VI > IV > II > V). Further-
more, the interaction between EBNA3C and RBPJ was 
shown to be essential for the induction of AID. Infection 
of primary B cells with recombinant EBV encoding an 
EBNA3C mutant for binding to RBPJ (Calderwood et 
al., 2011; Kalchschmidt et al., 2016) failed to induce AID 
expression (Fig. S1 B). Roles for RBPJ and p300 in the ac-
tivation of Notch-regulated superenhancers have recently 
been described (Wang et al., 2014), so this is consistent 
with our observations of AIC DA regulation by EBNA3C.
In summary, EBNA3C binds directly and specifically to 
four out of five of the well characterized regulatory elements 
of AIC DA, probably in association with RBPJ and perhaps 
other transcription factors. Increased levels of activation-as-
sociated epigenetic marks are deposited, catalyzed at least in 
part by recruitment of p300, leading to active transcription.
EBNA3C via AID causes SHM at IgH V-D-J
To determine whether AID was functional after induction 
by EBNA3C in the 3CHT LCL, cDNA corresponding to 
the IgH V-D-J region from the 3CHT A13 LCL time course 
(Fig. 2 A) was subjected to deep DNA sequence analysis (Table 
S1). The clonal distribution within −HT and +HT samples 
was determined from the V-D-J recombined IgH sequences, 
which act as molecular barcodes for each B cell clone. The 
starting population of the time course contained four major 
clones that all exhibited productive V-D-J rearrangement and 
together comprised >90% of the culture (Fig. 4 A and Table 
S2). The clonal development over the 60-d time course was 
found to be similar between the −HT and +HT conditions 
and thus allowed us to directly compare the two (Fig. 4 A 
and Table S2). Sequence analysis revealed significantly more 
nucleotide changes in the V-D-J region of samples with func-
tional EBNA3C (+HT) compared with nonfunctional EB-
NA3C (−HT) in all four analyzed major clones (Fig. 4 B). 
This was only detected from day 30 after activation of EB-
NA3C, which coincided with the time when the highest lev-
els of AID were present (Fig. 2 A) and was further increased at 
day 60 in all four clones independently of whether the clone 
had undergone expansion or reduction in size (Fig.  4  B). 
These data are consistent with EBNA3C-activated AID being 
functional and inducing SHM at the IgH locus.
Summary and future perspective
We have shown that the EBV oncoprotein EBNA3C spe-
cifically targets highly conserved regulatory elements in 
AIC DA and induces expression of AID in EBV-infected B 
cells. This then causes an increase in SHM at the IgH locus 
in non-GC B cells and might lead to genome-wide mu-
tations. As a result, EBNA3C could potentiate the risk of 
EBV-infected B cells progressing to B cell malignancies. For 
∼50 yr, it has been known that malaria and EBV infection 
in childhood are cofactors in eBL, but only recently was it 
shown that the parasite can directly induce AID expression 
and that chronic malaria infection creates GC environments 
favorable for the development of AID-dependent mature B 
cell lymphoma (Torgbor et al., 2014; Robbiani et al., 2015). 
Collectively with our data showing EBNA3C specifically 
targets and activates AID expression in EBV-infected B cells 
that could be the progenitors of BL, it is reasonable to spec-
ulate that the virus and parasite could synergize at this point 
in the etiology of eBL.
MAT ERI ALS AND MET HODS
Primary B cell infection. Recombinant EBNA3C KO and 
Rev viruses, virus production, and primary B cell isolation 
in the Savant genome browser and are shown for the same genomic coordinates. (B–F) ChIP-qPCR for H3K4me3 (B), H3K9ac (C), H3K27ac (D), acetyltrans-
ferase p300 (E), and RBPJ (F) on samples from 3CHT A13 time course at locations across the AID locus at GAP DH or myoglobin as indicated. Cells were grown 
in the absence (−HT) or presence of HT (+HT), and numbers indicate the day of harvest. ChIP values represent enrichment relative to input ± SD of triplicate 
qPCR reactions for ChIP and input of each sample. These are representative results of two biological replicates.
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have been described previously (Anderton et al., 2008; Skalska 
et al., 2013). B cell purity was assessed to be >90% CD20+ 
using anti–CD20-APC (eBioscience) staining and flow cyto-
metric analysis. RNA was harvested from uninfected primary 
B cells. Primary B cells (from anonymous donor buffy coats, 
purchased from the UK Blood Transfusion Service) were in-
fected with virus-containing supernatant, and infected cells 
were incubated in RPMI 1640 (Thermo Fisher Scientific) 
supplemented with 15% fetal bovine serum, penicillin, and 
streptomycin at 37°C and 5% CO2. Over a period of 30 d, 
infected cells were harvested for RNA extraction and re-
placed by fresh medium every 3 or 5 d.
Cell culture and time courses. All cells were cultured in 
RPMI 1640 medium supplemented with 10% fetal bovine 
serum, penicillin, and streptomycin either in the absence or 
presence of 400 nM HT (Sigma-Aldrich) at 37°C and 10% 
CO2. For the time course experiments, EBNA3C-condi-
tional LCLs (3CHT) on the p16-null background were used 
(Skalska et al., 2013). 3CHT A13 (established in the absence 
of HT) was used in a time course experiment over 60 d with 
RNA, protein, and ChIP samples taken every 3 d over the 
first 30 d and every 10 d until day 60. Cells were counted and 
diluted to 3 × 105 cells/ml at every time point until day 30 
and three times a week subsequently, but seeded at 3 × 105 
cells/ml the day before harvesting. After harvesting cells on 
day 30, the +HT culture was split in two, and for one of the 
cultures, the medium was replaced with fresh medium with-
out HT, which was subsequently cultured without HT until 
day 60 (washed). Replicate 3CHT A13 and 3CHT C19 
(established in the presence of HT, washed, and then grown 
without HT in the medium for >3 mo before the experi-
ment was started) time courses were performed over a period 
of 60 d. Cells were counted and split to 3 × 105 cells/ml the 
day before harvesting samples for RNA, protein, and ChIP. 
The 3CHT C19 time course was also used as a biological 
replicate for the ChIP analysis and showed essentially the 
same results as the 3CHT A13 time course. To analyze the 
expression of AID across cell lines, three in-house B95.8 
EBV–transformed LCLs, LCL GM12878, the EBV-negative 
BL cell line Ramos, the EBV-positive BL cell lines Akata, 
Oku, and Namalwa, the EBV-negative B cell lymphoma cell 
line BJAB, and the EBV-negative chronic myelogenous leu-
kemia cell line K562 were cultured and split to 3 × 105 cells/
ml the day before harvesting samples for RNA and protein.
RT-qPCR. RT-qPCR was performed essentially as described 
previously (Skalska et al., 2013). RNA from 4.5 × 106 cells 
was extracted using the RNeasy mini kit (QIA GEN), and 10 
ng cDNA was used for each qPCR reaction. GAP DH or 
GNB2L1 were used as housekeeping genes, and gene expres-
sion was expressed relative to primary B cells or LCL-HT on 
day 0 as indicated. The sequences of the primers used in this 
study are listed in Table S3.
Immunoblotting. Immunoblotting was performed essentially 
as described previously (Anderton et al., 2008; Skalska et al., 
2013). A total amount of 30 µg of radioimmunoprecipitation 
assay protein extract was separated on 10% SDS-PAGE using 
a Mini-PRO TEAN II cell (Bio-Rad Laboratories), trans-
ferred onto nitrocellulose membrane (Protran), and probed 
for AID (mAID-2; eBioscience) or γ-tubulin 
(T6557; Sigma-Aldrich).
ChIP. ChIPs for histone modifications, H3K4me3 (17-614; 
EMD Millipore), H3K9ac (17-658; EMD Millipore), and 
Figure 4. EBNA3C via AID induces SHM at the IgH variable region. (A) Network diagrams of B cell clones according to their rearranged V-D-J IgH 
sequence in samples of the 3CHT A13 time course show the clonal development of the four major clones (shown in red, blue, green, and orange) along 
minor clones (shown in gray) from the starting population at the beginning of the time course and after 60 d of culture with inactive (−HT) or active (+HT) 
EBNA3C. Each vertex represents a unique sequence, where relative vertex size is proportional to the number of identical reads. Edges join vertices that differ 
by single nucleotide differences, and clusters are collections of related, connected vertices. (B) Boxplots of the fold increase in the number of mutated V-D-J 
sequences for the four largest clones (same colors as in A) after 15, 30, and 60 d of culture with inactive (−HT) or active (+HT) EBNA3C. This is calculated 
as a cumulative change in the number of mutated V-D-J sequences at each time point relative to the starting population. P-values were determined by 
paired Student’s t test.
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H3K27ac (05-1334; EMD Millipore), were performed as de-
scribed previously (Skalska et al., 2013). For anti-Flag (2368S; 
Cell Signaling Technology), p300-C20 (SC585X; Santa Cruz 
Biotechnology, Inc.), and RBPJ (ab25949; Abcam) ChIPs, 4.5 
× 106 cells were incubated for 20 min in 1 ml of swelling 
buffer (25 mM Hepes, pH 7.8, 1.5 mM MgCl2, 10 mM KCl, 
0.1% NP-40, 1 mM DTT, 1 mM PMSF, 1 µg/ml aprotinin, 
and 1 µg/ml pepstatin A). Nuclei were resuspended in 1 ml of 
sonication buffer (50  mM Hepes, pH 7.8, 140  mM NaCl, 
1 mM EDTA, 1% Triton X-100, 0.1% sodium deoxycholate, 
0.1% SDS, 1 mM PMSF, 1 µg/ml aprotinin, and 1 µg/ml pep-
statin A) and sonicated for 1 h using an M220 (75-W peak 
power and 26 duty cycle for 200 cycles/burst at 6°C set tem-
perature; Covaris). Thereafter, a ChIP assay kit (17-295; EMD 
Millipore) was used according to the manufacturer’s protocol. 
DNA was cleaned using a PCR purification kit (QIAquick; 
QIA GEN) and was assayed by qPCR on QuantStudio 7 Flex 
(Thermo Fisher Scientific). Input DNA was 5% of DNA used 
in immunoprecipitations and diluted to 2.5% before PCR 
quantification. Enrichment relative to input was calculated 
using four fivefold dilution series, and error bars were calcu-
lated as SDs from triplicate PCR reactions for both input and 
ChIP. Sequences of the primers used in these assays 
are listed in Table S4.
SHM analysis at the IgH V-D-J locus. Sequencing of the re-
arranged IgH V-D-J locus was performed as described previ-
ously (Bashford-Rogers et al., 2013). In brief, mRNA 
extracted from samples of the 3CHT A13 time course (see 
the Cell culture and time courses section) was reverse tran-
scribed into cDNA that was used to PCR amplify IgH V-D-J 
as previously described. MiSeq libraries were prepared using 
Illumina protocols and sequenced using 300-bp paired-end 
MiSeq (Illumina). Raw MiSeq reads were filtered for base 
quality (median >32) using the QUA SR program (Watson et 
al., 2013). Nonimmunoglobulin sequences were removed, 
and only reads with significant similarity to reference IgHV 
genes from the International Immunogenetics Information 
System database (Lefranc et al., 2009) using BLA ST (Altschul 
et al., 1990) were retained (10−10 E-value threshold). Primer 
sequences were trimmed from the reads, and sequences were 
retained for analysis only if both primer sequences were iden-
tified. Network analyses were performed as described previ-
ously (Bashford-Rogers et al., 2013). To determine the fold 
increase in the number of mutated sequences in the top four 
clusters, the sequences from the HT+/− samples on days 0, 
15, 30, and 60 were combined clustered according to the cri-
teria in this paragraph. The largest four clusters in the com-
bined dataset were identified, and the time point at which 
each unique B cell receptor was first observed was deter-
mined. On this basis, the fold increase in the number of mu-
tated sequences was determined compared with the number 
of mutated sequences in each clone in the day 0 sample. 
P-values were determined by paired Student’s t tests in R.
Online supplemental material. Fig. S1 shows that repression 
of BCL6 is independent of EBNA3C and that induction of 
AID is dependent on the ability of EBNA3C to interact with 
RBPJ. Fig. S2 shows ChIP-qPCR verification of EBNA3C 
occupancy at regulatory regions of AIC DA. Fig. S3 shows the 
higher order chromatin structure of the AIC DA locus in LCL 
GM12878. Table S1 provides additional information on the 
number of sequencing reads and unique V-D-J rearrangements 
per sample. Table S2 provides additional information on the 
four major clones analyzed. Table S3 lists primers used in RT-
qPCR. Table S4 lists primers used in ChIP-qPCR. Online 
supplemental material is available at http ://www .jem .org /cgi 
/content /full /jem .20160120 /DC1.
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Figure S1. Repression of BCL6 is independent of EBNA3C, and induction of AID is dependent on the ability of EBNA3C to interact with 
RBPJ. (A) Infection of primary B cells with recombinant EBV expressing active (3CRev or 3CHT +HT) or inactive (3CKO or 3CHT −HT) EBNA3C. Gene 
expression of BCL6 was normalized to GAP DH or GNB2L1 and is shown relative to uninfected primary B cells. (B) Infection of primary B cells with 
recombinant EBV with wild-type EBNA3C or encoding an EBNA3C mutant that is unable to bind to RBPJ (RBPJ-binding mutant EBNA3C). AID mRNA 
expression was normalized to GNB2L1 and is shown relative to uninfected primary B cell. Results show mean ± SD of two biological replicates using 
B cells from different donors.
Figure S2. ChIP-qPCR verification of EBNA3C occupancy at regulatory regions of AIC DA. Anti-Flag ChIP was performed on LCLs with either EB-
NA3C-TAP or untagged (wt) EBNA3C and determined by qPCR at the indicated regulatory regions of AIC DA. ChIP values represent enrichment relative 
to input ± SD of triplicate qPCR reactions for ChIP and input of each sample. These are representative results of two biological replicates.
EBNA3C induces AID and somatic mutations | Kalchschmidt et al.S10
Figure S3. Higher order chromatin structure of the AIC DA locus in LCL GM12878. (A) Juicebox was used to display GM12878 in situ MboI 
combined (4.9 B) Hi-C map at 1-kb resolution (Rao et al., 2014). The intensity of each pixel represents the normalized (balanced) observed number of 
contacts between a pair of loci. Gene location for AIC DA and MFAP5, H3K27ac in LCL GM12878, topologically associating domain (yellow box), and 
locations of AID regulatory regions are indicated. (B) Schematic overview of higher order chromatin structure of the AIC DA locus in LCL GM12878 with 
chromatin looping indicated by black arrows between the promoter region of AIC DA and upstream enhancer elements IV, V, and VI.
Table S1. Total number of sequencing reads and unique V-D-J rearrangements per sample
Condition Day Technical replicate Number of reads Number of unique V-D-J rearrangements
−HT 0 A 198,362 11,219
B 194,823 6,186
C 149,604 8,850
D 147,598 8,878
15 A 201,034 9,582
30 A 137,139 6,154
B 184,503 3,756
60 A 150,120 5,676
B 164,873 3,156
+HT 15 A 179,405 9,541
30 A 194,136 8,621
B 191,113 3,613
60 A 221,088 7,424
B 187,481 3,559
C 204,514 7,022
S11JEM
Table S2. Characteristics of the four major clones according to the IMGT database
Clone color V gene J gene Nucleotide identity Percentage of culture
V-region J-region −HT +HT
d0 d30 d60 d30 d60
Blue IGHV3-23*01 IGHJ4*02 205/222 25/30 29.8 53.4 45.4 45.3 33.7
Red IGHV3-7*01 IGHJ4*02 200/219 31/31 31.3 39.6 54.5 39.7 65.9
Green IGHV6-1*02 IGHJ4*02 228/228 27/31 15.2 2.5 0.01 9.3 0.03
Orange IGHV7-4-1*02 IGHJ6*03 213/219 41/45 16.4 4.0 0.01 5.2 0.18
Table S3. Sequences of RT-qPCR primers
Gene Primer sequence (5′-3′) Reference
AIC DA                     Forward: AGC CGT TCT TAT TGC GAA GA
                    Reverse: TGA TGA ACC GGA GGA AGT TT
BCL6                     Forward: CTG CAG ATG GAG CAT GTT GT Tran et al. (2010)
                    Reverse: TCT TCA CGA GGA GGC TTG AT 
GNB2L1                     Forward: GCT TGC AGT TAG CCA GGT TC Zhang et al. (2005)
                    Reverse: GAG TGT GGC CTT CTC CTC TG
GAP DH Hs_GAP DH_2_SG QuantiTect primer assay, cat. no. QT01192646 QIA GEN
Table S4. Sequences of ChIP primers
Primer name Primer sequence (5′-3′) Reference
Region I                       Forward: GAG GAA GGC CAG TGC AAT CA
                      Reverse: CAG GGA GGC AAG AAG ACA CT
Region II                       Forward: GCT AGT TAA CTT TGT TGA TC
                      Reverse: CTA CTC AGG ACA GAA ATG AC
Region IV                       Forward: TGG ACA CCA GCT AGA TTG TTCA
                      Reverse: TCA CAC TTT CAC CCA CAC AGA
Region V                       Forward: CCT GTT CCT CTC CTT ACC GC
                      Reverse: ACG GAA GCC CTT GTA TCT TTGA
Region VI                       Forward: CAG CAA GTT TCC TTC TGC GA
                      Reverse: GCC ATT TCT GAC TCA GCA GC
Control                       Forward: GTC CTG TAC AGT AAC TAG AGA AAA
                      Reverse: GCA AAG CAA GAC GAC AAA GGA
GAP DH                       Forward: CGC TCT CTG CTC CTCC EMD Millipore
                      Reverse: TTT CTC TCC GCC CGT CCAC
Myoglobin                       Forward: GGA GAA AGA AGG GGA ATC ACA Delbarre et al. (2010)
                      Reverse: GAT AAA TAT AGC CAA CGC CACA
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